The relationship between the Hopkins symptom checklist-10 and diagnoses of anxiety and depression among inpatients with substance use disorders
Nordic Journal of Psychiatry · 2024
DOI: 10.1080/08039488.2024.2323124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nordic Journal of Psychiatry, 2024. Verfasst von Helle Wessel Andersson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Clinic of Substance Use and Addiction Medicine, St. Olavs University Hospital, Trondheim, Norway. Hauptthemen laut MEDLINE: Substance-Related Disorders, Anxiety Disorders, Checklist, Stress Disorders, Post-Traumatic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Norwegian University of Science and Technology, St. Olav’s University Hospital, Møre and Romsdal Hospital Trust.
Themen: Depression
Abstract (Originalsprache)
INTRODUCTION: The Hopkins Symptom Checklist-10 (HSCL-10) is a self-report inventory of anxiety and depression symptoms that may assist clinicians in screening for clinical conditions among patients with substance use disorder (SUD). We examined the HSCL-10 as a screening tool for anxiety and depressive disorders within a general population of SUD inpatients. METHODS: We used data from a cohort study of 611 SUD inpatients. Receiver operating characteristic (ROC) analyses were conducted, with and without covariates, to evaluate the potential of the HSCL-10 as a screening tool. This was explored using any anxiety disorder, especially posttraumatic stress disorder (PTSD), and any mood disorder, especially major depressive disorders, as the outcome criteria. Candidate covariates included gender, age, education, polydrug use and treatment center.Results: The HSCL-10 had a moderate ability to identify caseness (i.e. having or not having a clinical diagnosis) according to each outcome criterion, with the area under the ROC curve (AUC) varying from 0.64 to 0.66. Adding relevant covariates markedly enhanced the instrument's ability to identify those who met the criteria for any anxiety disorder (AUC = 0.77), especially PTSD (AUC = 0.82). CONCLUSION: In a real-world clinical setting, the HSCL-10 has fair-to-good clinical utility for identifying SUD inpatients who have comorbid clinical symptoms of anxiety disorders or PTSD, when combined with common background variables. The HSCL-10, a brief self-report screening tool, may serve as an efficient proxy for comprehensive interviews used in research and for clinical anxiety symptom screening among patients with SUD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research and Development, Clinic of Substance Use and Addiction Medicine, St. Olavs University Hospital, Trondheim, Norway.
- Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway.
ORCID-Profile: Helle Wessel Andersson
Förderung
- Norwegian University of Science and Technology
- St. Olav’s University Hospital
- Møre and Romsdal Hospital Trust
Zitieren
APA
Andersson, H. W., Nordfjærn, T., & Mosti, M. P. (2024). The relationship between the Hopkins symptom checklist-10 and diagnoses of anxiety and depression among inpatients with substance use disorders. Nordic Journal of Psychiatry. https://doi.org/10.1080/08039488.2024.2323124
Vancouver
Andersson HW, Nordfjærn T, Mosti MP. The relationship between the Hopkins symptom checklist-10 and diagnoses of anxiety and depression among inpatients with substance use disorders. Nordic Journal of Psychiatry. 2024. doi:10.1080/08039488.2024.2323124
BibTeX
@article{Andersson2024,
author = {Andersson, Helle Wessel and Nordfjærn, Trond and Mosti, Mats P},
title = {The relationship between the Hopkins symptom checklist-10 and diagnoses of anxiety and depression among inpatients with substance use disorders},
journal = {Nordic Journal of Psychiatry},
year = {2024},
doi = {10.1080/08039488.2024.2323124}
}
EUVIMED